{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,30]],"date-time":"2026-09-30T06:47:10Z","timestamp":1790750830661,"version":"4.1.0"},"reference-count":263,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2021,4,1]],"date-time":"2021-04-01T00:00:00Z","timestamp":1617235200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2023,8,18]],"date-time":"2023-08-18T00:00:00Z","timestamp":1692316800000},"content-version":"vor","delay-in-days":869,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"}],"content-domain":{"domain":["neurotherapeuticsjournal.org","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Neurotherapeutics"],"published-print":{"date-parts":[[2021,4]]},"DOI":"10.1007\/s13311-021-01026-5","type":"journal-article","created":{"date-parts":[[2021,3,29]],"date-time":"2021-03-29T15:02:40Z","timestamp":1617030160000},"page":"709-727","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":15,"title":["Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease"],"prefix":"10.1016","volume":"18","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-5356-5537","authenticated-orcid":false,"given":"Rachel F.","family":"Buckley","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib1","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1212\/WNL.0000000000002923","article-title":"A\/T\/N: An unbiased descriptive classification scheme for Alzheimer disease biomarkers","volume":"87","author":"Jack","year":"2016","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib2","doi-asserted-by":"crossref","first-page":"207","DOI":"10.1016\/S1474-4422(12)70291-0","article-title":"Tracking pathophysiological processes in Alzheimer's disease: an updated hypothetical model of dynamic biomarkers","volume":"12","author":"Jack","year":"2013","journal-title":"Lancet Neurol"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib3","doi-asserted-by":"crossref","first-page":"205","DOI":"10.1016\/j.jalz.2018.09.001","article-title":"Multisite study of the relationships between antemortem [11C] PIB-PET Centiloid values and postmortem measures of Alzheimer\u2019s disease neuropathology","volume":"15","author":"La Joie","year":"2019","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib4","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1001\/jamapsychiatry.2017.3391","article-title":"Association of Cerebral Amyloid-\u03b2 Aggregation With Cognitive Functioning in Persons Without Dementia","volume":"75","author":"Jansen","year":"2018","journal-title":"JAMA Psychiatry"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib5","doi-asserted-by":"crossref","first-page":"347","DOI":"10.1038\/s41467-019-14159-1","article-title":"Functional brain architecture is associated with the rate of tau accumulation in Alzheimer's disease","volume":"11","author":"Franzmeier","year":"2020","journal-title":"Nature Communications"},{"issue":"11","key":"10.1007\/s13311-021-01026-5_bib6","doi-asserted-by":"crossref","first-page":"1379","DOI":"10.1001\/jamaneurol.2014.2031","article-title":"Synergistic effect of \u03b2-amyloid and neurodegeneration on cognitive decline in clinically normal individuals","volume":"71","author":"Mormino","year":"2014","journal-title":"JAMA Neurology"},{"key":"10.1007\/s13311-021-01026-5_bib7","doi-asserted-by":"crossref","unstructured":"Marinescu, R.V., et al. TADPOLE Challenge: Accurate Alzheimer's Disease Prediction Through Crowdsourced Forecasting of Future Data. in Predictive Intelligence in Medicine. 2019. Cham: Springer International Publishing.","DOI":"10.1007\/978-3-030-32281-6_1"},{"key":"10.1007\/s13311-021-01026-5_bib8","unstructured":"Marinescu, R.V., et al., Tadpole challenge: Prediction of longitudinal evolution in Alzheimer's disease. arXiv preprint arXiv: 1805.03909, 2018."},{"key":"10.1007\/s13311-021-01026-5_bib9","unstructured":"Dumitrescu, L., et al., Genetic Variants and Functional Pathways Associated with Resilience to Alzheimer's Disease. bioRxiv, 2020."},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib10","doi-asserted-by":"crossref","first-page":"306","DOI":"10.1002\/ana.20009","article-title":"Imaging brain amyloid in Alzheimer's disease with Pittsburgh Compound-B","volume":"55","author":"Klunk","year":"2004","journal-title":"Annals of Neurology"},{"issue":"11","key":"10.1007\/s13311-021-01026-5_bib11","doi-asserted-by":"crossref","first-page":"1528","DOI":"10.1038\/sj.jcbfm.9600146","article-title":"Kinetic modeling of amyloid binding in humans using PET imaging and Pittsburgh Compound-B","volume":"25","author":"Price","year":"2005","journal-title":"Journal of Cerebral Blood Flow & Metabolism"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib12","doi-asserted-by":"crossref","first-page":"378","DOI":"10.2967\/jnumed.111.090340","article-title":"Performance characteristics of amyloid PET with florbetapir F 18 in patients with Alzheimer's disease and cognitively normal subjects","volume":"53","author":"Joshi","year":"2012","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib13","doi-asserted-by":"crossref","first-page":"70","DOI":"10.2967\/jnumed.112.109009","article-title":"Amyloid-\u03b2 imaging with Pittsburgh compound B and florbetapir: comparing radiotracers and quantification methods","volume":"54","author":"Landau","year":"2013","journal-title":"Journal of Nuclear Medicine"},{"issue":"12","key":"10.1007\/s13311-021-01026-5_bib14","doi-asserted-by":"crossref","first-page":"2053","DOI":"10.1007\/s00259-017-3749-6","article-title":"18 F-Florbetaben PET beta-amyloid binding expressed in Centiloids","volume":"44","author":"Rowe","year":"2017","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib15","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1007\/s00259-012-2088-x","article-title":"Comparison of 11C-PiB and 18F-florbetaben for A\u03b2 imaging in ageing and Alzheimer's disease","volume":"39","author":"Villemagne","year":"2012","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"supplement 1","key":"10.1007\/s13311-021-01026-5_bib16","first-page":"191","article-title":"Higher A\u03b2 burden in subjective memory complainers: A flutemetamol sub-study in AIBL","volume":"55","author":"Rowe","year":"2014","journal-title":"Journal of Nuclear Medicine"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib17","doi-asserted-by":"crossref","first-page":"319","DOI":"10.1002\/ana.22068","article-title":"18F-flutemetamol amyloid imaging in Alzheimer disease and mild cognitive impairment: A phase 2 trial","volume":"68","author":"Vandenberghe","year":"2010","journal-title":"Annals of Neurology"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib18","doi-asserted-by":"crossref","first-page":"880","DOI":"10.2967\/jnumed.112.114785","article-title":"Head-to-head comparison of 11C-PiB and 18F-AZD4694 (NAV4694) for \u03b2-amyloid imaging in aging and dementia","volume":"54","author":"Rowe","year":"2013","journal-title":"Journal of Nuclear Medicine"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib19","doi-asserted-by":"crossref","first-page":"885","DOI":"10.1056\/NEJMp1208061","article-title":"Brain amyloid imaging\u2014FDA approval of florbetapir F18 injection","volume":"367","author":"Yang","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"11","key":"10.1007\/s13311-021-01026-5_bib20","doi-asserted-by":"crossref","first-page":"1711","DOI":"10.2967\/jnumed.116.185017","article-title":"Clinical Use and Utility of Amyloid Imaging","volume":"58","author":"Barthel","year":"2017","journal-title":"Journal of Nuclear Medicine"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib21","doi-asserted-by":"crossref","first-page":"1409","DOI":"10.2967\/jnumed.120.252411","article-title":"First Tau PET Tracer Approved: Toward Accurate In Vivo Diagnosis of Alzheimer Disease","volume":"61","author":"Barthel","year":"2020","journal-title":"Journal of Nuclear Medicine"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib22","doi-asserted-by":"crossref","first-page":"1599","DOI":"10.2967\/jnumed.115.171678","article-title":"Preclinical characterization of 18F-MK-6240, a promising PET tracer for in vivo quantification of human neurofibrillary tangles","volume":"57","author":"Hostetler","year":"2016","journal-title":"Journal of nuclear medicine"},{"key":"10.1007\/s13311-021-01026-5_bib23","doi-asserted-by":"crossref","unstructured":"Leuzy, A., et al., Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders. JAMA neurology, 2020.","DOI":"10.1001\/jamaneurol.2020.0989"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib24","doi-asserted-by":"crossref","first-page":"2178","DOI":"10.1007\/s00259-019-04397-2","article-title":"Discovery and preclinical characterization of [18F]PI-2620, a next-generation tau PET tracer for the assessment of tau pathology in Alzheimer's disease and other tauopathies","volume":"46","author":"Kroth","year":"2019","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"8","key":"10.1007\/s13311-021-01026-5_bib25","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1038\/s41380-018-0342-8","article-title":"Tau PET imaging in neurodegenerative tauopathies\u2014still a challenge","volume":"24","author":"Leuzy","year":"2019","journal-title":"Molecular Psychiatry"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib26","doi-asserted-by":"crossref","first-page":"114","DOI":"10.1016\/S1474-4422(14)70252-2","article-title":"Tau imaging: early progress and future directions","volume":"14","author":"Villemagne","year":"2015","journal-title":"Lancet Neurol"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib27","doi-asserted-by":"crossref","first-page":"110","DOI":"10.1002\/ana.24546","article-title":"Tau positron emission tomographic imaging in aging and early Alzheimer disease","volume":"79","author":"Johnson","year":"2016","journal-title":"Annals of neurology"},{"key":"10.1007\/s13311-021-01026-5_bib28","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/j.neuroimage.2017.07.050","article-title":"AV-1451 PET imaging of tau pathology in preclinical Alzheimer disease: Defining a summary measure","volume":"161","author":"Mishra","year":"2017","journal-title":"NeuroImage"},{"key":"10.1007\/s13311-021-01026-5_bib29","doi-asserted-by":"crossref","first-page":"448","DOI":"10.1016\/j.neuroimage.2017.05.058","article-title":"Comparison of multiple tau-PET measures as biomarkers in aging and Alzheimer's disease","volume":"157","author":"Maass","year":"2017","journal-title":"NeuroImage"},{"key":"10.1007\/s13311-021-01026-5_bib30","doi-asserted-by":"crossref","unstructured":"Brier, M.R., et al., Tau and A\u03b2 imaging, CSF measures, and cognition in Alzheimer's disease. Science Translational Medicine, 2016. 8(338): p. 338ra66\u2013338ra66.","DOI":"10.1126\/scitranslmed.aaf2362"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib31","first-page":"748","article-title":"Relationships between flortaucipir PET tau binding and amyloid burden, clinical diagnosis, age and cognition","volume":"140","author":"Pontecorvo","year":"2017","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01026-5_bib32","unstructured":"Pereira, J.B., et al., Spatial patterns of tau deposition are associated with amyloid, ApoE, sex, and cognitive decline in older adults. European Journal of Nuclear Medicine and Molecular Imaging, 2020: p. 1\u201310."},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib33","doi-asserted-by":"crossref","first-page":"271","DOI":"10.1093\/brain\/awx320","article-title":"Widespread brain tau and its association with ageing Braak stage and Alzheimer's dementia","volume":"141","author":"Lowe","year":"2017","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01026-5_bib34","first-page":"21","article-title":"Tau-PET uptake: Regional variation in average SUVR and impact of amyloid deposition","volume":"6","author":"Vemuri","year":"2017","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1007\/s13311-021-01026-5_bib35","doi-asserted-by":"crossref","first-page":"191","DOI":"10.1016\/j.neuroimage.2017.02.051","article-title":"Amyloid and tau PET demonstrate region-specific associations in normal older people","volume":"150","author":"Lockhart","year":"2017","journal-title":"NeuroImage"},{"issue":"9","key":"10.1007\/s13311-021-01026-5_bib36","doi-asserted-by":"crossref","first-page":"1070","DOI":"10.1001\/jamaneurol.2016.2078","article-title":"Evaluation of Tau Imaging in Staging Alzheimer Disease and Revealing Interactions Between \u03b2-Amyloid and Tauopathy","volume":"73","author":"Wang","year":"2016","journal-title":"JAMA Neurology"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib37","doi-asserted-by":"crossref","first-page":"1539","DOI":"10.1093\/brain\/aww023","article-title":"Regional profiles of the candidate tau PET ligand 18 F-AV-1451 recapitulate key features of Braak histopathological stages","volume":"139","author":"Schwarz","year":"2016","journal-title":"Brain"},{"issue":"9","key":"10.1007\/s13311-021-01026-5_bib38","doi-asserted-by":"crossref","first-page":"920","DOI":"10.1212\/WNL.0000000000003050","article-title":"Temporal T807 binding correlates with CSF tau and phospho-tau in normal elderly","volume":"87","author":"Chhatwal","year":"2016","journal-title":"Neurology"},{"issue":"8","key":"10.1007\/s13311-021-01026-5_bib39","doi-asserted-by":"crossref","first-page":"2249","DOI":"10.1093\/brain\/aww139","article-title":"The relationship between cerebrospinal fluid markers of Alzheimer pathology and positron emission tomography tau imaging","volume":"139","author":"Gordon","year":"2016","journal-title":"Brain"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib40","doi-asserted-by":"crossref","first-page":"1551","DOI":"10.1093\/brain\/aww027","article-title":"Tau PET patterns mirror clinical and neuroanatomical variability in Alzheimer's disease","volume":"139","author":"Ossenkoppele","year":"2016","journal-title":"Brain"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib41","doi-asserted-by":"crossref","first-page":"247","DOI":"10.1002\/ana.24711","article-title":"In vivo cortical spreading pattern of tau and amyloid in the Alzheimer disease spectrum","volume":"80","author":"Cho","year":"2016","journal-title":"Annals of Neurology"},{"key":"10.1007\/s13311-021-01026-5_bib42","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/j.neurobiolaging.2018.08.022","article-title":"Widespread distribution of tauopathy in preclinical Alzheimer's disease","volume":"72","author":"Schultz","year":"2018","journal-title":"Neurobiology of Aging"},{"key":"10.1007\/s13311-021-01026-5_bib43","doi-asserted-by":"crossref","unstructured":"Sanchez, J.S., et al., The cortical origin and initial spread of medial temporal tauopathy in Alzheimer's disease assessed with positron emission tomography. Science Translational Medicine, 2021. 13(577).","DOI":"10.1126\/scitranslmed.abc0655"},{"key":"10.1007\/s13311-021-01026-5_bib44","doi-asserted-by":"crossref","unstructured":"Dor\u00e9, V., et al., Relationship between amyloid and tau levels and its impact on tau spreading. European Journal of Nuclear Medicine and Molecular Imaging, 2021.","DOI":"10.1007\/s00259-021-05191-9"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib45","doi-asserted-by":"crossref","first-page":"181","DOI":"10.1002\/ana.25395","article-title":"The impact of amyloid-beta and tau on prospective cognitive decline in older individuals","volume":"85","author":"Sperling","year":"2019","journal-title":"Annals of Neurology"},{"issue":"9","key":"10.1007\/s13311-021-01026-5_bib46","doi-asserted-by":"crossref","first-page":"e859","DOI":"10.1212\/WNL.0000000000006075","article-title":"Influence of tau PET, amyloid PET, and hippocampal volume on cognition in Alzheimer disease","volume":"91","author":"Aschenbrenner","year":"2018","journal-title":"Neurology"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib47","doi-asserted-by":"crossref","first-page":"320","DOI":"10.1093\/brain\/awz378","article-title":"Amyloid and tau imaging biomarkers explain cognitive decline from late middle-age","volume":"143","author":"Betthauser","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib48","doi-asserted-by":"crossref","first-page":"239","DOI":"10.1007\/BF00308809","article-title":"Neuropathological stageing of Alzheimer-related changes","volume":"82","author":"Braak","year":"1991","journal-title":"Acta Neuropathol"},{"issue":"12","key":"10.1007\/s13311-021-01026-5_bib49","doi-asserted-by":"crossref","first-page":"1791","DOI":"10.1212\/WNL.58.12.1791","article-title":"Phases of A\u03b2-deposition in the human brain and its relevance for the development of AD","volume":"58","author":"Thal","year":"2002","journal-title":"Neurology"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib50","doi-asserted-by":"crossref","first-page":"166","DOI":"10.2967\/jnumed.119.235879","article-title":"The spatial-temporal ordering of amyloid pathology and opportunities for PET imaging","volume":"61","author":"Fantoni","year":"2020","journal-title":"Journal of Nuclear Medicine"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib51","doi-asserted-by":"crossref","first-page":"743","DOI":"10.1016\/j.jalz.2018.01.002","article-title":"Early striatal amyloid deposition distinguishes Down syndrome and autosomal dominant Alzheimer\u2019s disease from late-onset amyloid deposition","volume":"14","author":"Cohen","year":"2018","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib52","doi-asserted-by":"crossref","first-page":"1281","DOI":"10.1016\/j.jalz.2018.04.011","article-title":"PET staging of amyloidosis using striatum","volume":"14","author":"Hanseeuw","year":"2018","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"13","key":"10.1007\/s13311-021-01026-5_bib53","doi-asserted-by":"crossref","first-page":"2368","DOI":"10.1007\/s00259-018-4081-5","article-title":"Amyloid involvement in subcortical regions predicts cognitive decline","volume":"45","author":"Cho","year":"2018","journal-title":"European Journal of Nuclear Medicine and Molecular Imaging"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib54","doi-asserted-by":"crossref","first-page":"557","DOI":"10.1007\/s00401-018-1897-9","article-title":"Estimation of amyloid distribution by [18F]flutemetamol PET predicts the neuropathological phase of amyloid \u03b2-protein deposition","volume":"136","author":"Thal","year":"2018","journal-title":"Acta Neuropathologica"},{"issue":"20","key":"10.1007\/s13311-021-01026-5_bib55","doi-asserted-by":"crossref","first-page":"2031","DOI":"10.1212\/WNL.0000000000004643","article-title":"In vivo staging of regional amyloid deposition","volume":"89","author":"Grothe","year":"2017","journal-title":"Neurology"},{"issue":"11","key":"10.1007\/s13311-021-01026-5_bib56","doi-asserted-by":"crossref","first-page":"1319","DOI":"10.1001\/jamaneurol.2019.2214","article-title":"Staging \u03b2-Amyloid Pathology With Amyloid Positron Emission Tomography","volume":"76","author":"Mattsson","year":"2019","journal-title":"JAMA Neurology"},{"issue":"19","key":"10.1007\/s13311-021-01026-5_bib57","doi-asserted-by":"crossref","first-page":"e1809","DOI":"10.1212\/WNL.0000000000006469","article-title":"Regional amyloid accumulation and cognitive decline in initially amyloid-negative adults","volume":"91","author":"Farrell","year":"2018","journal-title":"Neurology"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib58","doi-asserted-by":"crossref","first-page":"822","DOI":"10.2967\/jnumed.117.194720","article-title":"Spatiotemporal Distribution of \u03b2-Amyloid in Alzheimer Disease Is the Result of Heterogeneous Regional Carrying Capacities","volume":"59","author":"Whittington","year":"2018","journal-title":"Journal of Nuclear Medicine"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib59","doi-asserted-by":"crossref","first-page":"971","DOI":"10.1016\/j.neuron.2016.01.028","article-title":"PET Imaging of Tau Deposition in the Aging Human Brain","volume":"89","author":"Sch\u00f6ll","year":"2016","journal-title":"Neuron"},{"key":"10.1007\/s13311-021-01026-5_bib60","unstructured":"Lowe, V.J., et al., Tau-positron emission tomography correlates with neuropathology findings. Alzheimer\u2019s & Dementia, 2019."},{"key":"10.1007\/s13311-021-01026-5_bib61","doi-asserted-by":"crossref","unstructured":"Franzmeier, N., et al., Patient-centered connectivity-based prediction of tau pathology spread in Alzheimer's disease. Science Advances, 2020. 6(48): p. eabd1327.","DOI":"10.1126\/sciadv.abd1327"},{"issue":"7","key":"10.1007\/s13311-021-01026-5_bib62","doi-asserted-by":"crossref","first-page":"813","DOI":"10.1001\/jamaneurol.2017.0263","article-title":"Hierarchical Organization of Tau and Amyloid Deposits in the Cerebral Cortex","volume":"74","author":"Sepulcre","year":"2017","journal-title":"JAMA neurology"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib63","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1002\/hbm.24401","article-title":"Data-driven approaches for tau-PET imaging biomarkers in Alzheimer's disease","volume":"40","author":"Vogel","year":"2019","journal-title":"Human Brain Mapping"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib64","doi-asserted-by":"crossref","first-page":"1517","DOI":"10.1093\/brain\/awy059","article-title":"Longitudinal tau PET in ageing and Alzheimer's disease","volume":"141","author":"Jack","year":"2018","journal-title":"Brain"},{"issue":"7","key":"10.1007\/s13311-021-01026-5_bib65","doi-asserted-by":"crossref","first-page":"2281","DOI":"10.1093\/brain\/awaa155","article-title":"Longitudinal neuroimaging biomarkers differ across Alzheimer's disease phenotypes","volume":"143","author":"Sintini","year":"2020","journal-title":"Brain"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib66","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1002\/ana.25406","article-title":"Longitudinal tau accumulation and atrophy in aging and alzheimer disease","volume":"85","author":"Harrison","year":"2019","journal-title":"Annals of Neurology"},{"issue":"S4","key":"10.1007\/s13311-021-01026-5_bib67","doi-asserted-by":"crossref","DOI":"10.1002\/alz.043876","article-title":"The accumulation rate of tau aggregates is higher in females and younger individuals","volume":"16","author":"Smith","year":"2020","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib68","doi-asserted-by":"crossref","first-page":"3136","DOI":"10.1093\/brain\/awaa248","article-title":"Predicting future rates of tau accumulation on PET","volume":"143","author":"Jack","year":"2020","journal-title":"Brain"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib69","doi-asserted-by":"crossref","first-page":"1723","DOI":"10.1093\/brain\/awz090","article-title":"A multicentre longitudinal study of flortaucipir (18F) in normal ageing, mild cognitive impairment and Alzheimer's disease dementia","volume":"142","author":"Pontecorvo","year":"2019","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01026-5_bib70","doi-asserted-by":"crossref","unstructured":"Scott, M.R., et al., Inferior temporal tau is associated with accelerated prospective cortical thinning in clinically normal older adults. NeuroImage, 2020: p. 116991.","DOI":"10.1016\/j.neuroimage.2020.116991"},{"issue":"11","key":"10.1007\/s13311-021-01026-5_bib71","doi-asserted-by":"crossref","first-page":"3477","DOI":"10.1093\/brain\/awaa276","article-title":"18F-flortaucipir PET to autopsy comparisons in Alzheimer's disease and other neurodegenerative diseases","volume":"143","author":"Soleimani-Meigooni","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib72","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1186\/s40478-016-0315-6","article-title":"An autoradiographic evaluation of AV-1451 Tau PET in dementia","volume":"4","author":"Lowe","year":"2016","journal-title":"Acta Neuropathologica Communications"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib73","doi-asserted-by":"crossref","first-page":"787","DOI":"10.1002\/ana.24517","article-title":"Validating novel tau positron emission tomography tracer [F-18]-AV-1451 (T807) on postmortem brain tissue","volume":"78","author":"Marqui\u00e9","year":"2015","journal-title":"Annals of Neurology"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib74","doi-asserted-by":"crossref","first-page":"1444","DOI":"10.2967\/jnumed.118.224113","article-title":"Effect of Off-Target Binding on 18F-Flortaucipir Variability in Healthy Controls Across the Life Span","volume":"60","author":"Baker","year":"2019","journal-title":"Journal of Nuclear Medicine"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib75","doi-asserted-by":"crossref","first-page":"332","DOI":"10.2967\/jnumed.116.175273","article-title":"Reference Tissue-Based Kinetic Evaluation of 18F-AV-1451 for Tau Imaging","volume":"58","author":"Baker","year":"2017","journal-title":"Journal of Nuclear Medicine"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib76","doi-asserted-by":"crossref","first-page":"307","DOI":"10.1002\/ana.24706","article-title":"[F-18] AV-1451 PET retention in choroid plexus: more than \u201coff-target\u201d binding","volume":"80","author":"Ikonomovic","year":"2016","journal-title":"Annals of neurology"},{"key":"10.1007\/s13311-021-01026-5_bib77","doi-asserted-by":"crossref","unstructured":"Malarte, M.-L., A. Nordberg, and L. Lemoine, Characterization of MK6240, a tau PET tracer, in autopsy brain tissue from Alzheimer's disease cases. European Journal of Nuclear Medicine and Molecular Imaging, 2020.","DOI":"10.1007\/s00259-020-05035-y"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib78","doi-asserted-by":"crossref","first-page":"342","DOI":"10.1007\/s00259-019-04496-0","article-title":"Head-to-head comparison of tau positron emission tomography tracers [18 F] flortaucipir and [18 F] RO948","volume":"47","author":"Smith","year":"2020","journal-title":"European journal of nuclear medicine and molecular imaging"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib79","doi-asserted-by":"crossref","first-page":"911","DOI":"10.2967\/jnumed.119.236224","article-title":"Tau PET imaging with 18F-PI-2620 in patients with Alzheimer disease and healthy controls: a first-in-humans study","volume":"61","author":"Mueller","year":"2020","journal-title":"Journal of Nuclear Medicine"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib80","doi-asserted-by":"crossref","first-page":"37","DOI":"10.1186\/s40478-019-0686-6","article-title":"Autoradiography validation of novel tau PET tracer [F-18]-MK-6240 on human postmortem brain tissue","volume":"7","author":"Aguero","year":"2019","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1007\/s13311-021-01026-5_bib81","doi-asserted-by":"crossref","unstructured":"Mormino, E.C., et al., Tau PET imaging with 18F-PI-2620 in aging and neurodegenerative diseases. European Journal of Nuclear Medicine and Molecular Imaging, 2020.","DOI":"10.1007\/s00259-020-04923-7"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib82","doi-asserted-by":"crossref","first-page":"13","DOI":"10.1186\/s13195-019-0470-7","article-title":"18F-flortaucipir (AV-1451) tau PET in frontotemporal dementia syndromes","volume":"11","author":"Tsai","year":"2019","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"8","key":"10.1007\/s13311-021-01026-5_bib83","doi-asserted-by":"crossref","first-page":"955","DOI":"10.1001\/jamaneurol.2020.0989","article-title":"Diagnostic Performance of RO948 F 18 Tau Positron Emission Tomography in the Differentiation of Alzheimer Disease From Other Neurodegenerative Disorders","volume":"77","author":"Leuzy","year":"2020","journal-title":"JAMA Neurology"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib84","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1001\/jamaneurol.2014.4821","article-title":"Age, sex, and APOE \u03b54 effects on memory, brain structure, and \u03b2-amyloid across the adult life span","volume":"72","author":"Jack","year":"2015","journal-title":"JAMA Neurology"},{"issue":"8","key":"10.1007\/s13311-021-01026-5_bib85","doi-asserted-by":"crossref","first-page":"1275","DOI":"10.1016\/j.neurobiolaging.2010.04.007","article-title":"Amyloid imaging results from the Australian Imaging, Biomarkers and Lifestyle (AIBL) study of aging","volume":"31","author":"Rowe","year":"2010","journal-title":"Neurobiology of Aging"},{"issue":"15","key":"10.1007\/s13311-021-01026-5_bib86","doi-asserted-by":"crossref","first-page":"1570","DOI":"10.1212\/WNL.0b013e31826e2696","article-title":"Indicators of amyloid burden in a population-based study of cognitively normal elderly","volume":"79","author":"Mielke","year":"2012","journal-title":"Neurology"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib87","doi-asserted-by":"crossref","first-page":"735","DOI":"10.1001\/jamaneurol.2020.0387","article-title":"Association of Factors With Elevated Amyloid Burden in Clinically Normal Older Individuals","volume":"77","author":"Sperling","year":"2020","journal-title":"JAMA Neurology"},{"key":"10.1007\/s13311-021-01026-5_bib88","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1016\/j.neurobiolaging.2017.01.024","article-title":"Excessive tau accumulation in the parieto-occipital cortex characterizes early-onset Alzheimer's disease","volume":"53","author":"Cho","year":"2017","journal-title":"Neurobiology of Aging"},{"key":"10.1007\/s13311-021-01026-5_bib89","doi-asserted-by":"crossref","unstructured":"La Joie, R., et al., Association of APOE4 and clinical variability in Alzheimer disease with the pattern of tau-and amyloid-PET. Neurology, 2020.","DOI":"10.1212\/WNL.0000000000011270"},{"issue":"9","key":"10.1007\/s13311-021-01026-5_bib90","doi-asserted-by":"crossref","first-page":"2286","DOI":"10.1093\/brain\/awx171","article-title":"Distinct 18F-AV-1451 tau PET retention patterns in early- and late-onset Alzheimer's disease","volume":"140","author":"Sch\u00f6ll","year":"2017","journal-title":"Brain"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib91","doi-asserted-by":"crossref","first-page":"675","DOI":"10.1016\/j.jalz.2018.12.016","article-title":"The role of age on tau PET uptake and gray matter atrophy in atypical Alzheimer\u2019s disease","volume":"15","author":"Whitwell","year":"2019","journal-title":"Alzheimer\u2019s & dementia : the journal of the Alzheimer\u2019s Association"},{"issue":"12","key":"10.1007\/s13311-021-01026-5_bib92","doi-asserted-by":"crossref","first-page":"3805","DOI":"10.1093\/brain\/awaa327","article-title":"The accumulation rate of tau aggregates is higher in females and younger amyloid-positive subjects","volume":"143","author":"Smith","year":"2020","journal-title":"Brain"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib93","doi-asserted-by":"crossref","first-page":"542","DOI":"10.1001\/jamaneurol.2018.4693","article-title":"Sex differences in the association between regional tau and global amyloid PET","volume":"76","author":"Buckley","year":"2019","journal-title":"JAMA Neurol"},{"key":"10.1007\/s13311-021-01026-5_bib94","doi-asserted-by":"crossref","unstructured":"Buckley, R.F., et al., Sex mediates relationships between regional tau pathology and cognitive decline. Annals of Neurology, 2020. In press.","DOI":"10.1002\/ana.25878"},{"key":"10.1007\/s13311-021-01026-5_bib95","doi-asserted-by":"crossref","unstructured":"Wisch, J.K., et al., Sex-related Differences in Tau Positron Emission Tomography (PET) and the Effects of Hormone Therapy (HT). Alzheimer Disease & Associated Disorders, 2020.","DOI":"10.1097\/WAD.0000000000000393"},{"issue":"17","key":"10.1007\/s13311-021-01026-5_bib96","doi-asserted-by":"crossref","first-page":"4959","DOI":"10.7150\/thno.35366","article-title":"Sex modulates the ApoE \u03b54 effect on brain tau deposition measured by (18)F-AV-1451 PET in individuals with mild cognitive impairment","volume":"9","author":"Liu","year":"2019","journal-title":"Theranostics"},{"key":"10.1007\/s13311-021-01026-5_bib97","doi-asserted-by":"crossref","unstructured":"Ossenkoppele, R., et al., The impact of demographic, clinical, genetic, and imaging variables on tau PET status. European Journal of Nuclear Medicine and Molecular Imaging, 2020.","DOI":"10.1007\/s00259-020-05099-w"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib98","doi-asserted-by":"crossref","first-page":"e166","DOI":"10.1212\/WNL.0000000000009781","article-title":"Sex-driven modifiers of Alzheimer risk","volume":"95","author":"Rahman","year":"2020","journal-title":"Neurology"},{"issue":"13","key":"10.1007\/s13311-021-01026-5_bib99","first-page":"1382","article-title":"Sex differences in Alzheimer risk","volume":"89","author":"Mosconi","year":"2017","journal-title":"Brain imaging of endocrine vs chronologic aging"},{"issue":"15","key":"10.1007\/s13311-021-01026-5_bib100","doi-asserted-by":"crossref","first-page":"e2065","DOI":"10.1212\/WNL.0000000000010527","article-title":"Association of years to parent's sporadic onset and risk factors with neural integrity and Alzheimer biomarkers","volume":"95","author":"Arenaza-Urquijo","year":"2020","journal-title":"Neurology"},{"issue":"9","key":"10.1007\/s13311-021-01026-5_bib101","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1016\/j.jalz.2018.04.010","article-title":"Sex, Amyloid, and APOEe4 and risk of cognitive decline in preclinical Alzheimer's disease: findings from three well-characterized cohorts","volume":"14","author":"Buckley","year":"2018","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1007\/s13311-021-01026-5_bib102","doi-asserted-by":"crossref","unstructured":"Lim, Y.Y., et al., Stronger effect of amyloid load than APOE genotype on cognitive decline in healthy older adults. Neurology, 2012. 79.","DOI":"10.1212\/WNL.0b013e31826e9ae6"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib103","doi-asserted-by":"crossref","first-page":"1239","DOI":"10.1016\/j.neurobiolaging.2014.12.008","article-title":"APOE \u03b54 moderates amyloid-related memory decline in preclinical Alzheimer\u2019s disease","volume":"36","author":"Lim","year":"2015","journal-title":"Neurobiol Aging"},{"key":"10.1007\/s13311-021-01026-5_bib104","doi-asserted-by":"crossref","first-page":"46","DOI":"10.1016\/j.neurobiolaging.2020.06.001","article-title":"Impact of APOE-\u03b54 carriage on the onset and rates of neocortical A\u03b2-amyloid deposition","volume":"95","author":"Burnham","year":"2020","journal-title":"Neurobiology of Aging"},{"key":"10.1007\/s13311-021-01026-5_bib105","doi-asserted-by":"crossref","unstructured":"Ghisays, V., et al., Brain imaging measurements of fibrillar amyloid-\u03b2 burden, paired helical filament tau burden, and atrophy in cognitively unimpaired persons with two, one, and no copies of the APOE \u03b54 allele. Alzheimer\u2019s & Dementia, 2019.","DOI":"10.1016\/j.jalz.2019.08.195"},{"key":"10.1007\/s13311-021-01026-5_bib106","doi-asserted-by":"crossref","unstructured":"Lim, Y.Y., E.C. Mormino, and F.t.A.s.D.N. Initiative, APOE genotype and early \u03b2-amyloid accumulation in older adults without dementia. Neurology, 2017. 89(10): p. 1028\u20131034.","DOI":"10.1212\/WNL.0000000000004336"},{"issue":"7","key":"10.1007\/s13311-021-01026-5_bib107","doi-asserted-by":"crossref","first-page":"913","DOI":"10.1016\/j.jalz.2018.02.009","article-title":"Prevalence of the apolipoprotein E \u03b54 allele in amyloid \u03b2 positive subjects across the spectrum of Alzheimer\u2019s disease","volume":"14","author":"Mattsson","year":"2018","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib108","doi-asserted-by":"crossref","first-page":"77","DOI":"10.1186\/s13195-018-0403-x","article-title":"Greater tau load and reduced cortical thickness in APOE \u03b54-negative Alzheimer's disease: a cohort study","volume":"10","author":"Mattsson","year":"2018","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib109","doi-asserted-by":"crossref","first-page":"470","DOI":"10.1001\/jamaneurol.2019.4421","article-title":"Association of Apolipoprotein E \u03b54 With Medial Temporal Tau Independent of Amyloid-\u03b2","volume":"77","author":"Therriault","year":"2020","journal-title":"JAMA Neurology"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib110","doi-asserted-by":"crossref","first-page":"248","DOI":"10.1002\/ana.25142","article-title":"[18F] AV-1451 clustering of entorhinal and cortical uptake in Alzheimer's disease","volume":"83","author":"Whitwell","year":"2018","journal-title":"Annals of neurology"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib111","doi-asserted-by":"crossref","first-page":"292","DOI":"10.1016\/j.jalz.2018.09.009","article-title":"Perspectives on ethnic and racial disparities in Alzheimer\u2019s disease and related dementias: Update and areas of immediate need","volume":"15","author":"Babulal","year":"2019","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib112","doi-asserted-by":"crossref","first-page":"251","DOI":"10.1001\/jamaneurol.2018.3444","article-title":"Biomarkers for Alzheimer Dementia in Diverse Racial and Ethnic Minorities\u2014A Public Health Priority","volume":"76","author":"Barnes","year":"2019","journal-title":"JAMA Neurology"},{"key":"10.1007\/s13311-021-01026-5_bib113","doi-asserted-by":"crossref","unstructured":"Morris JC, Schindler SE, McCue LM, et al. Assessment of racial disparities in biomarkers for Alzheimer disease. JAMA neurology 2019;76:264-273.","DOI":"10.1001\/jamaneurol.2018.4249"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib114","doi-asserted-by":"crossref","first-page":"473","DOI":"10.1212\/WNL.0000000000002914","article-title":"The ARIC-PET amyloid imaging study: brain amyloid differences by age, race, sex, and APOE","volume":"87","author":"Gottesman","year":"2016","journal-title":"Neurology"},{"key":"10.1007\/s13311-021-01026-5_bib115","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.3233\/JAD-191291","article-title":"Examining Cognitive Decline Across Black and White Participants in the Harvard Aging Brain Study","volume":"75","author":"Amariglio","year":"2020","journal-title":"Journal of Alzheimer's Disease"},{"issue":"7","key":"10.1007\/s13311-021-01026-5_bib116","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0123743","article-title":"Brain Amyloid Deposition and Longitudinal Cognitive Decline in Nondemented Older Subjects: Results from a Multi-Ethnic Population","volume":"10","author":"Gu","year":"2015","journal-title":"PLOS ONE"},{"key":"10.1007\/s13311-021-01026-5_bib117","doi-asserted-by":"crossref","unstructured":"Jack, C.R., et al., Different definitions of neurodegeneration produce similar amyloid\/neurodegeneration biomarker group findings. Brain, 2015.","DOI":"10.1093\/brain\/awv283"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib118","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1002\/ana.22628","article-title":"An operational approach to National Institute on Aging\u2013Alzheimer\u2019s Association criteria for preclinical Alzheimer disease","volume":"71","author":"Jack","year":"2012","journal-title":"Annals of Neurology"},{"key":"10.1007\/s13311-021-01026-5_bib119","doi-asserted-by":"crossref","unstructured":"Jack, C.R., et al., Rates of \u03b2-amyloid accumulation are independent of hippocampal neurodegeneration. Neurology, 2014.","DOI":"10.1212\/WNL.0000000000000386"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib120","doi-asserted-by":"crossref","first-page":"1310","DOI":"10.1093\/brain\/awn320","article-title":"Episodic memory loss is related to hippocampal-mediated \u03b2-amyloid deposition in elderly subjects","volume":"132","author":"Mormino","year":"2009","journal-title":"Brain"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib121","doi-asserted-by":"crossref","first-page":"3230","DOI":"10.1093\/brain\/awz268","article-title":"The bivariate distribution of amyloid-\u03b2 and tau: relationship with established neurocognitive clinical syndromes","volume":"142","author":"Jack","year":"2019","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01026-5_bib122","doi-asserted-by":"crossref","unstructured":"Weigand, A.J., et al., Is tau in the absence of amyloid on the Alzheimer's continuum?: A study of discordant PET positivity. Brain Communications, 2019. 2(1).","DOI":"10.1093\/braincomms\/fcz046"},{"issue":"21","key":"10.1007\/s13311-021-01026-5_bib123","doi-asserted-by":"crossref","first-page":"e2233","DOI":"10.1212\/WNL.0000000000009485","article-title":"The implications of different approaches to define AT(N) in Alzheimer disease","volume":"94","author":"Mattsson-Carlgren","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib124","doi-asserted-by":"crossref","first-page":"435","DOI":"10.1016\/S1474-4422(17)30077-7","article-title":"Age-specific and sex-specific prevalence of cerebral \u03b2-amyloidosis, tauopathy, and neurodegeneration in cognitively unimpaired individuals aged 50\u201395 years: a cross-sectional study","volume":"16","author":"Jack","year":"2017","journal-title":"The Lancet Neurology"},{"key":"10.1007\/s13311-021-01026-5_bib125","unstructured":"Guo, T., et al., Longitudinal Cognitive and Biomarker Measurements Support a Unidirectional Pathway in Alzheimer's Disease Pathophysiology. Biological Psychiatry, 2020."},{"key":"10.1007\/s13311-021-01026-5_bib126","doi-asserted-by":"crossref","unstructured":"Iaccarino, L., et al., Spatial Relationships between Molecular Pathology and Neurodegeneration in the Alzheimer's Disease Continuum. Cerebral Cortex, 2020.","DOI":"10.1093\/cercor\/bhaa184"},{"issue":"9","key":"10.1007\/s13311-021-01026-5_bib127","doi-asserted-by":"crossref","first-page":"795","DOI":"10.1056\/NEJMoa1202753","article-title":"Clinical and Biomarker Changes in Dominantly Inherited Alzheimer's Disease","volume":"367","author":"Bateman","year":"2012","journal-title":"New England Journal of Medicine"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib128","doi-asserted-by":"crossref","first-page":"1529","DOI":"10.1093\/brain\/awy050","article-title":"Data-driven models of dominantly-inherited Alzheimer's disease progression","volume":"141","author":"Oxtoby","year":"2018","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01026-5_bib129","doi-asserted-by":"crossref","unstructured":"Archetti, D., et al., Multi-study validation of data-driven disease progression models to characterize evolution of biomarkers in Alzheimer's disease. NeuroImage: Clinical, 2019. 24: p. 101954.","DOI":"10.1016\/j.nicl.2019.101954"},{"key":"10.1007\/s13311-021-01026-5_bib130","doi-asserted-by":"crossref","unstructured":"Luo, J., et al., Sequence of Alzheimer disease biomarker changes in cognitively normal adults. A cross-sectional study, 2020: p. https:\/\/doi.org\/10.1212\/WNL.0000000000010747.","DOI":"10.1212\/WNL.0000000000010747"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib131","first-page":"657","article-title":"Bayesian latent time joint mixed-effects model of progression in the Alzheimer\u2019s Disease Neuroimaging Initiative","volume":"10","author":"Li","year":"2018","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1007\/s13311-021-01026-5_bib132","doi-asserted-by":"crossref","unstructured":"Insel, P.S., et al., Neuroanatomical spread of amyloid \u03b2 and tau in Alzheimer's disease: implications for primary prevention. Brain Communications, 2020. 2(1).","DOI":"10.1093\/braincomms\/fcaa007"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib133","first-page":"e12007","article-title":"Amyloid duration is associated with preclinical cognitive decline and tau PET","volume":"12","author":"Koscik","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"19","key":"10.1007\/s13311-021-01026-5_bib134","doi-asserted-by":"crossref","first-page":"4482","DOI":"10.1523\/JNEUROSCI.0485-18.2018","article-title":"Subthreshold Amyloid Predicts Tau Deposition in Aging","volume":"38","author":"Leal","year":"2018","journal-title":"The Journal of Neuroscience"},{"issue":"8","key":"10.1007\/s13311-021-01026-5_bib135","doi-asserted-by":"crossref","first-page":"915","DOI":"10.1001\/jamaneurol.2019.1424","article-title":"Association of Amyloid and Tau With Cognition in Preclinical Alzheimer Disease: A Longitudinal Study","volume":"76","author":"Hanseeuw","year":"2019","journal-title":"JAMA Neurology"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib136","doi-asserted-by":"crossref","first-page":"2612","DOI":"10.1038\/s41467-020-15701-2","article-title":"Spread of pathological tau proteins through communicating neurons in human Alzheimer's disease","volume":"11","author":"Vogel","year":"2020","journal-title":"Nature Communications"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib137","doi-asserted-by":"crossref","first-page":"568","DOI":"10.1093\/brain\/awx353","article-title":"Networks of tau distribution in Alzheimer's disease","volume":"141","author":"Hoenig","year":"2018","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01026-5_bib138","doi-asserted-by":"crossref","unstructured":"Hansson, O., et al., Tau Pathology Distribution in Alzheimer's disease Corresponds Differentially to Cognition-Relevant Functional Brain Networks. Frontiers in Neuroscience, 2017. 11(167).","DOI":"10.3389\/fnins.2017.00167"},{"key":"10.1007\/s13311-021-01026-5_bib139","doi-asserted-by":"crossref","unstructured":"Pereira, J.B., et al., Amyloid and tau accumulate across distinct spatial networks and are differentially associated with brain connectivity. eLife, 2019. 8: p. e50830.","DOI":"10.7554\/eLife.50830"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib140","doi-asserted-by":"crossref","first-page":"547","DOI":"10.1093\/brain\/awv338","article-title":"Cascading network failure across the Alzheimer's disease spectrum","volume":"139","author":"Jones","year":"2016","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01026-5_bib141","doi-asserted-by":"crossref","unstructured":"Adams, J.N., et al., Cortical tau deposition follows patterns of entorhinal functional connectivity in aging. eLife, 2019. 8: p. e49132.","DOI":"10.7554\/eLife.49132"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib142","doi-asserted-by":"crossref","first-page":"1093","DOI":"10.1093\/brain\/awz026","article-title":"Functional connectivity associated with tau levels in ageing, Alzheimer's, and small vessel disease","volume":"142","author":"Franzmeier","year":"2019","journal-title":"Brain"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib143","doi-asserted-by":"crossref","first-page":"856","DOI":"10.1016\/j.neuron.2019.08.037","article-title":"Patient-Tailored, Connectivity-Based Forecasts of Spreading Brain Atrophy","volume":"104","author":"Brown","year":"2019","journal-title":"Neuron"},{"key":"10.1007\/s13311-021-01026-5_bib144","doi-asserted-by":"crossref","unstructured":"Ossenkoppele, R., et al., Tau covariance patterns in Alzheimer's disease patients match intrinsic connectivity networks in the healthy brain. NeuroImage: Clinical, 2019. 23: p. 101848.","DOI":"10.1016\/j.nicl.2019.101848"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib145","first-page":"e12016","article-title":"In vivo network models identify sex differences in the spread of tau pathology across the brain","volume":"12","author":"Shokouhi","year":"2020","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"15","key":"10.1007\/s13311-021-01026-5_bib146","doi-asserted-by":"crossref","first-page":"4219","DOI":"10.1002\/hbm.25121","article-title":"Longitudinal validity of PET-based staging of regional amyloid deposition","volume":"41","author":"Jelistratova","year":"2020","journal-title":"Human Brain Mapping"},{"issue":"11","key":"10.1007\/s13311-021-01026-5_bib147","doi-asserted-by":"crossref","first-page":"e1538","DOI":"10.1212\/WNL.0000000000010256","article-title":"Multitracer model for staging cortical amyloid deposition using PET imaging","volume":"95","author":"Collij","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib148","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1016\/S1474-4422(13)70044-9","article-title":"Amyloid \u03b2 deposition, neurodegeneration, and cognitive decline in sporadic Alzheimer\u2019s disease: a prospective cohort study","volume":"12","author":"Villemagne","year":"2013","journal-title":"Lancet Neurol"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib149","doi-asserted-by":"crossref","first-page":"890","DOI":"10.1212\/WNL.0b013e3182840bbe","article-title":"Brain \u03b2-amyloid load approaches a plateau","volume":"80","author":"Jack","year":"2013","journal-title":"Neurology"},{"issue":"7","key":"10.1007\/s13311-021-01026-5_bib150","doi-asserted-by":"crossref","first-page":"2020","DOI":"10.1093\/brain\/awv112","article-title":"Existing Pittsburgh Compound-B positron emission tomography thresholds are too high: statistical and pathological evaluation","volume":"138","author":"Villeneuve","year":"2015","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01026-5_bib151","unstructured":"Farrell, M., et al., Defining the lowest A\u03b2-PET threshold for predicting future A\u03b2 accumulation and cognitive decline Neurology, 2020. In press."},{"key":"10.1007\/s13311-021-01026-5_bib152","doi-asserted-by":"crossref","first-page":"l6927","DOI":"10.1136\/bmj.l6927","article-title":"Machine learning and artificial intelligence research for patient benefit: 20 critical questions on transparency, replicability, ethics, and effectiveness","volume":"368","author":"Vollmer","year":"2020","journal-title":"BMJ"},{"issue":"12","key":"10.1007\/s13311-021-01026-5_bib153","doi-asserted-by":"crossref","first-page":"e677","DOI":"10.1016\/S2589-7500(20)30200-4","article-title":"Time to reality check the promises of machine learning-powered precision medicine","volume":"2","author":"Wilkinson","year":"2020","journal-title":"The Lancet Digital Health"},{"issue":"14","key":"10.1007\/s13311-021-01026-5_bib154","doi-asserted-by":"crossref","first-page":"1341","DOI":"10.1212\/WNL.0b013e31828ab35d","article-title":"Meta-analysis of amyloid-cognition relations in cognitively normal older adults","volume":"80","author":"Hedden","year":"2013","journal-title":"Neurology"},{"key":"10.1007\/s13311-021-01026-5_bib155","doi-asserted-by":"crossref","first-page":"117203","DOI":"10.1016\/j.neuroimage.2020.117203","article-title":"Predicting Alzheimer's disease progression using deep recurrent neural networks","volume":"222","author":"Nguyen","year":"2020","journal-title":"NeuroImage"},{"key":"10.1007\/s13311-021-01026-5_bib156","doi-asserted-by":"crossref","unstructured":"Chen, T. and C. Guestrin, XGBoost: A Scalable Tree Boosting System, in Proceedings of the 22nd ACM SIGKDD International Conference on Knowledge Discovery and Data Mining. 2016, Association for Computing Machinery: San Francisco, California, USA. p. 785\u2013794.","DOI":"10.1145\/2939672.2939785"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib157","doi-asserted-by":"crossref","first-page":"e142","DOI":"10.1212\/WNL.0000000000008679","article-title":"Contribution of TDP and hippocampal sclerosis to hippocampal volume loss in older-old persons","volume":"94","author":"Yu","year":"2020","journal-title":"Neurology"},{"issue":"18","key":"10.1007\/s13311-021-01026-5_bib158","doi-asserted-by":"crossref","first-page":"e1916","DOI":"10.1212\/WNL.0000000000009362","article-title":"The presubiculum links incipient amyloid and tau pathology to memory function in older persons","volume":"94","author":"Jacobs","year":"2020","journal-title":"Neurology"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib159","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1002\/alz.12079","article-title":"Contribution of mixed pathology to medial temporal lobe atrophy in Alzheimer\u2019s disease","volume":"16","author":"de Flores","year":"2020","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"11","key":"10.1007\/s13311-021-01026-5_bib160","doi-asserted-by":"crossref","first-page":"3621","DOI":"10.1093\/brain\/awz277","article-title":"Antemortem volume loss mirrors TDP-43 staging in older adults with non-frontotemporal lobar degeneration","volume":"142","author":"Bejanin","year":"2019","journal-title":"Brain"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib161","doi-asserted-by":"crossref","first-page":"635","DOI":"10.1093\/brain\/awz414","article-title":"Morphometric network differences in ageing versus Alzheimer's disease dementia","volume":"143","author":"Pichet Binette","year":"2020","journal-title":"Brain"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib162","first-page":"439","article-title":"Progress update from the hippocampal subfields group","volume":"11","author":"Olsen","year":"2019","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib163","doi-asserted-by":"crossref","first-page":"60","DOI":"10.1186\/s13195-019-0510-3","article-title":"Associations between quantitative [18F]flortaucipir tau PET and atrophy across the Alzheimer's disease spectrum","volume":"11","author":"Timmers","year":"2019","journal-title":"Alzheimer\u2019s Research & Therapy"},{"key":"10.1007\/s13311-021-01026-5_bib164","doi-asserted-by":"crossref","unstructured":"La Joie, R., et al., Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. Science translational medicine, 2020. 12(524).","DOI":"10.1126\/scitranslmed.aau5732"},{"key":"10.1007\/s13311-021-01026-5_bib165","first-page":"245","article-title":"Cross-sectional and longitudinal atrophy is preferentially associated with tau rather than amyloid \u03b2 positron emission tomography pathology","volume":"10","author":"Gordon","year":"2018","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1007\/s13311-021-01026-5_bib166","doi-asserted-by":"crossref","unstructured":"La Joie, R., et al., Prospective longitudinal atrophy in Alzheimer's disease correlates with the intensity and topography of baseline tau-PET. Science Translational Medicine, 2020. 12(524): p. eaau5732.","DOI":"10.1126\/scitranslmed.aau5732"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib167","doi-asserted-by":"crossref","first-page":"e601","DOI":"10.1212\/WNL.0000000000006875","article-title":"Associations between tau, A\u03b2, and cortical thickness with cognition in Alzheimer disease","volume":"92","author":"Ossenkoppele","year":"2019","journal-title":"Neurology"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib168","doi-asserted-by":"crossref","first-page":"570","DOI":"10.1016\/j.jalz.2018.12.001","article-title":"Predicting diagnosis and cognition with 18F-AV-1451 tau PET and structural MRI in Alzheimer\u2019s disease","volume":"15","author":"Mattsson","year":"2019","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"8","key":"10.1007\/s13311-021-01026-5_bib169","doi-asserted-by":"crossref","first-page":"2023","DOI":"10.1016\/j.neurobiolaging.2013.02.020","article-title":"Alzheimer's disease: connecting findings from graph theoretical studies of brain networks","volume":"34","author":"Tijms","year":"2013","journal-title":"Neurobiology of Aging"},{"issue":"18","key":"10.1007\/s13311-021-01026-5_bib170","doi-asserted-by":"crossref","first-page":"4756","DOI":"10.1523\/JNEUROSCI.0141-08.2008","article-title":"Structural Insights into Aberrant Topological Patterns of Large-Scale Cortical Networks in Alzheimer's Disease","volume":"28","author":"He","year":"2008","journal-title":"The Journal of Neuroscience"},{"key":"10.1007\/s13311-021-01026-5_bib171","doi-asserted-by":"crossref","first-page":"75","DOI":"10.1016\/j.neurobiolaging.2017.09.011","article-title":"Gray matter networks and clinical progression in subjects with predementia Alzheimer's disease","volume":"61","author":"Tijms","year":"2018","journal-title":"Neurobiology of Aging"},{"key":"10.1007\/s13311-021-01026-5_bib172","doi-asserted-by":"crossref","first-page":"154","DOI":"10.1016\/j.neurobiolaging.2015.10.015","article-title":"Gray matter network disruptions and amyloid beta in cognitively normal adults","volume":"37","author":"Tijms","year":"2016","journal-title":"Neurobiology of Aging"},{"key":"10.1007\/s13311-021-01026-5_bib173","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1016\/j.neurobiolaging.2020.05.008","article-title":"Single-subject gray matter networks predict future cortical atrophy in preclinical Alzheimer's disease","volume":"94","author":"Dicks","year":"2020","journal-title":"Neurobiology of Aging"},{"key":"10.1007\/s13311-021-01026-5_bib174","doi-asserted-by":"crossref","unstructured":"Dicks, E., et al., Grey Matter Network Trajectories Across The Alzheimer's Disease Continuum And Relation To Cognition. Brain Communications, 2020.","DOI":"10.1093\/braincomms\/fcaa177"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib175","doi-asserted-by":"crossref","first-page":"3638","DOI":"10.1093\/cercor\/bhx236","article-title":"Abnormal Structural Brain Connectome in Individuals with Preclinical Alzheimer's Disease","volume":"28","author":"Pereira","year":"2017","journal-title":"Cerebral Cortex"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib176","doi-asserted-by":"crossref","first-page":"1251","DOI":"10.1093\/cercor\/bhy031","article-title":"Global white matter diffusion characteristics predict longitudinal cognitive change independently of amyloid status in clinically normal older adults","volume":"29","author":"Rabin","year":"2019","journal-title":"Cerebral Cortex"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib177","doi-asserted-by":"crossref","first-page":"3065","DOI":"10.1093\/brain\/awy229","article-title":"White matter diffusion alterations precede symptom onset in autosomal dominant Alzheimer's disease","volume":"141","author":"Araque Caballero","year":"2018","journal-title":"Brain"},{"issue":"8","key":"10.1007\/s13311-021-01026-5_bib178","doi-asserted-by":"crossref","first-page":"2483","DOI":"10.1093\/brain\/awz162","article-title":"White matter hyperintensities: relationship to amyloid and tau burden","volume":"142","author":"Graff-Radford","year":"2019","journal-title":"Brain"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib179","doi-asserted-by":"crossref","first-page":"651","DOI":"10.1002\/alz.12062","article-title":"Age-dependent amyloid deposition is associated with white matter alterations in cognitively normal adults during the adult life span","volume":"16","author":"Caballero","year":"2020","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1007\/s13311-021-01026-5_bib180","doi-asserted-by":"crossref","first-page":"116944","DOI":"10.1016\/j.neuroimage.2020.116944","article-title":"White matter hyperintensities are associated with subthreshold amyloid accumulation","volume":"218","author":"Moscoso","year":"2020","journal-title":"NeuroImage"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib181","doi-asserted-by":"crossref","first-page":"1233","DOI":"10.1093\/brain\/awaa068","article-title":"Medial temporal lobe connectivity and its associations with cognition in early Alzheimer's disease","volume":"143","author":"Berron","year":"2020","journal-title":"Brain"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib182","doi-asserted-by":"crossref","first-page":"1860","DOI":"10.1523\/JNEUROSCI.5062-08.2009","article-title":"Cortical Hubs Revealed by Intrinsic Functional Connectivity: Mapping, Assessment of Stability, and Relation to Alzheimer's Disease","volume":"29","author":"Buckner","year":"2009","journal-title":"The Journal of Neuroscience"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib183","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1016\/j.biopsych.2009.08.024","article-title":"Amyloid Plaques Disrupt Resting State Default Mode Network Connectivity in Cognitively Normal Elderly","volume":"67","author":"Sheline","year":"2010","journal-title":"Biological Psychiatry"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib184","doi-asserted-by":"crossref","first-page":"2399","DOI":"10.1093\/cercor\/bhr025","article-title":"Relationships between Beta-Amyloid and Functional Connectivity in Different Components of the Default Mode Network in Aging","volume":"21","author":"Mormino","year":"2011","journal-title":"Cerebral Cortex"},{"issue":"40","key":"10.1007\/s13311-021-01026-5_bib185","doi-asserted-by":"crossref","first-page":"12686","DOI":"10.1523\/JNEUROSCI.3189-09.2009","article-title":"Disruption of Functional Connectivity in Clinically Normal Older Adults Harboring Amyloid Burden","volume":"29","author":"Hedden","year":"2009","journal-title":"The Journal of Neuroscience"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib186","doi-asserted-by":"crossref","first-page":"29","DOI":"10.1212\/WNL.0000000000004059","article-title":"Functional network integrity presages cognitive decline in preclinical Alzheimer disease","volume":"89","author":"Buckley","year":"2017","journal-title":"Neurology"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib187","doi-asserted-by":"crossref","first-page":"757","DOI":"10.1016\/j.neurobiolaging.2013.10.081","article-title":"Functional connectivity and graph theory in preclinical Alzheimer's disease","volume":"35","author":"Brier","year":"2014","journal-title":"Neurobiology of Aging"},{"issue":"16","key":"10.1007\/s13311-021-01026-5_bib188","doi-asserted-by":"crossref","first-page":"4323","DOI":"10.1523\/JNEUROSCI.3263-16.2017","article-title":"Phases of hyperconnectivity and hypoconnectivity in the default mode and salience networks track with amyloid and tau in clinically normal individuals","volume":"37","author":"Schultz","year":"2017","journal-title":"Journal of Neuroscience"},{"issue":"7806","key":"10.1007\/s13311-021-01026-5_bib189","doi-asserted-by":"crossref","first-page":"71","DOI":"10.1038\/s41586-020-2247-3","article-title":"APOE4 leads to blood\u2013brain barrier dysfunction predicting cognitive decline","volume":"581","author":"Montagne","year":"2020","journal-title":"Nature"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib190","doi-asserted-by":"crossref","first-page":"270","DOI":"10.1038\/s41591-018-0297-y","article-title":"Blood\u2013brain barrier breakdown is an early biomarker of human cognitive dysfunction","volume":"25","author":"Nation","year":"2019","journal-title":"Nature Medicine"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib191","doi-asserted-by":"crossref","first-page":"296","DOI":"10.1016\/j.neuron.2014.12.032","article-title":"Blood-brain barrier breakdown in the aging human hippocampus","volume":"85","author":"Montagne","year":"2015","journal-title":"Neuron"},{"issue":"44","key":"10.1007\/s13311-021-01026-5_bib192","doi-asserted-by":"crossref","first-page":"8573","DOI":"10.1523\/JNEUROSCI.1230-20.2020","article-title":"Associations between Vascular Function and Tau PET Are Associated with Global Cognition and Amyloid","volume":"40","author":"Albrecht","year":"2020","journal-title":"The Journal of Neuroscience"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib193","doi-asserted-by":"crossref","first-page":"1318","DOI":"10.1038\/s41593-018-0234-x","article-title":"The role of brain vasculature in neurodegenerative disorders","volume":"21","author":"Sweeney","year":"2018","journal-title":"Nature Neuroscience"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib194","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.jalz.2018.07.222","article-title":"Vascular dysfunction\u2014The disregarded partner of Alzheimer\u2019s disease","volume":"15","author":"Sweeney","year":"2019","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib195","doi-asserted-by":"crossref","first-page":"12351","DOI":"10.1038\/s41598-019-48910-x","article-title":"Image processing approaches to enhance perivascular space visibility and quantification using MRI","volume":"9","author":"Sepehrband","year":"2019","journal-title":"Scientific Reports"},{"key":"10.1007\/s13311-021-01026-5_bib196","first-page":"348","article-title":"Nonparenchymal fluid is the source of increased mean diffusivity in preclinical Alzheimer\u2019s disease","volume":"11","author":"Sepehrband","year":"2019","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"8000","key":"10.1007\/s13311-021-01026-5_bib197","doi-asserted-by":"crossref","first-page":"1403","DOI":"10.1016\/S0140-6736(76)91936-X","article-title":"SELECTIVE LOSS OF CENTRAL CHOLINERGIC NEURONS IN ALZHEIMER'S DISEASE","volume":"308","author":"Davies","year":"1976","journal-title":"The Lancet"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib198","doi-asserted-by":"crossref","first-page":"327","DOI":"10.1016\/j.neurobiolaging.2006.02.007","article-title":"Locus coeruleus neurofibrillary degeneration in aging, mild cognitive impairment and early Alzheimer's disease","volume":"28","author":"Grudzien","year":"2007","journal-title":"Neurobiology of Aging"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib199","doi-asserted-by":"crossref","first-page":"13249","DOI":"10.1038\/ncomms13249","article-title":"Basal forebrain degeneration precedes and predicts the cortical spread of Alzheimer's pathology","volume":"7","author":"Schmitz","year":"2016","journal-title":"Nature Communications"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib200","doi-asserted-by":"crossref","first-page":"1210","DOI":"10.1016\/j.neurobiolaging.2012.10.018","article-title":"Longitudinal measures of cholinergic forebrain atrophy in the transition from healthy aging to Alzheimer's disease","volume":"34","author":"Grothe","year":"2013","journal-title":"Neurobiology of Aging"},{"issue":"9","key":"10.1007\/s13311-021-01026-5_bib201","doi-asserted-by":"crossref","first-page":"805","DOI":"10.1016\/j.biopsych.2011.06.019","article-title":"Atrophy of the Cholinergic Basal Forebrain Over the Adult Age Range and in Early Stages of Alzheimer's Disease","volume":"71","author":"Grothe","year":"2012","journal-title":"Biological Psychiatry"},{"issue":"5S","key":"10.1007\/s13311-021-01026-5_bib202","doi-asserted-by":"crossref","first-page":"S344","DOI":"10.1016\/j.jalz.2013.09.011","article-title":"Basal forebrain atrophy and cortical amyloid deposition in nondemented elderly subjects","volume":"10","author":"Grothe","year":"2014","journal-title":"Alzheimer\u2019s & Dementia"},{"key":"10.1007\/s13311-021-01026-5_bib203","doi-asserted-by":"crossref","unstructured":"Kerbler, G.M., et al., Basal forebrain atrophy correlates with amyloid \u03b2 burden in Alzheimer\u2019s disease. NeuroImage: Clinical, 2015. 7: p. 105\u2013113.","DOI":"10.1016\/j.nicl.2014.11.015"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib204","doi-asserted-by":"crossref","first-page":"482","DOI":"10.1016\/j.neurobiolaging.2013.09.029","article-title":"Cholinergic basal forebrain atrophy predicts amyloid burden in Alzheimer's disease","volume":"35","author":"Teipel","year":"2014","journal-title":"Neurobiology of aging"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib205","doi-asserted-by":"crossref","first-page":"993","DOI":"10.1093\/brain\/awaa012","article-title":"Basal forebrain volume reliably predicts the cortical spread of Alzheimer's degeneration","volume":"143","author":"Fern\u00e1ndez-Cabello","year":"2020","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01026-5_bib206","unstructured":"Betts, M.J., et al., Locus coeruleus imaging as a biomarker for noradrenergic dysfunction in neurodegenerative diseases. 2019, Oxford University Press."},{"key":"10.1007\/s13311-021-01026-5_bib207","first-page":"281","article-title":"Locus coeruleus MRI contrast is reduced in Alzheimer\u2019s disease dementia and correlates with CSF A\u03b2 levels","volume":"11","author":"Betts","year":"2019","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"11","key":"10.1007\/s13311-021-01026-5_bib208","doi-asserted-by":"crossref","first-page":"1203","DOI":"10.1038\/s41562-019-0715-2","article-title":"Rostral locus coeruleus integrity is associated with better memory performance in older adults","volume":"3","author":"Dahl","year":"2019","journal-title":"Nature Human Behaviour"},{"key":"10.1007\/s13311-021-01026-5_bib209","doi-asserted-by":"crossref","first-page":"117301","DOI":"10.1016\/j.neuroimage.2020.117301","article-title":"A probabilistic atlas of locus coeruleus pathways to transentorhinal cortex for connectome imaging in Alzheimer's disease","volume":"223","author":"Sun","year":"2020","journal-title":"NeuroImage"},{"key":"10.1007\/s13311-021-01026-5_bib210","doi-asserted-by":"crossref","unstructured":"Jacobs, H.I.L., et al., Dynamic behavior of the locus coeruleus during arousal-related memory processing in a multi-modal 7T fMRI paradigm. eLife, 2020. 9: p. e52059.","DOI":"10.7554\/eLife.52059"},{"issue":"9","key":"10.1007\/s13311-021-01026-5_bib211","doi-asserted-by":"crossref","first-page":"1060","DOI":"10.1001\/jamaneurol.2019.1632","article-title":"Performance of Fully Automated Plasma Assays as Screening Tests for Alzheimer Disease-Related \u03b2-Amyloid Status","volume":"76","author":"Palmqvist","year":"2019","journal-title":"JAMA Neurology"},{"issue":"17","key":"10.1007\/s13311-021-01026-5_bib212","doi-asserted-by":"crossref","first-page":"e1647","DOI":"10.1212\/WNL.0000000000008081","article-title":"High-precision plasma \u03b2-amyloid 42\/40 predicts current and future brain amyloidosis","volume":"93","author":"Schindler","year":"2019","journal-title":"Neurology"},{"issue":"7691","key":"10.1007\/s13311-021-01026-5_bib213","doi-asserted-by":"crossref","first-page":"249","DOI":"10.1038\/nature25456","article-title":"High performance plasma amyloid-\u03b2 biomarkers for Alzheimer's disease","volume":"554","author":"Nakamura","year":"2018","journal-title":"Nature"},{"key":"10.1007\/s13311-021-01026-5_bib214","first-page":"510","article-title":"Plasma amyloid beta levels are associated with cerebral amyloid and tau deposition","volume":"11","author":"Risacher","year":"2019","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib215","doi-asserted-by":"crossref","first-page":"422","DOI":"10.1016\/S1474-4422(20)30071-5","article-title":"Blood phosphorylated tau 181 as a biomarker for Alzheimer's disease: a diagnostic performance and prediction modelling study using data from four prospective cohorts","volume":"19","author":"Karikari","year":"2020","journal-title":"The Lancet Neurology"},{"issue":"8","key":"10.1007\/s13311-021-01026-5_bib216","doi-asserted-by":"crossref","first-page":"989","DOI":"10.1016\/j.jalz.2018.02.013","article-title":"Plasma phospho-tau181 increases with Alzheimer\u2019s disease clinical severity and is associated with tau- and amyloid-positron emission tomography","volume":"14","author":"Mielke","year":"2018","journal-title":"Alzheimer\u2019s & Dementia"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib217","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1038\/s41591-020-0755-1","article-title":"Plasma P-tau181 in Alzheimer's disease: relationship to other biomarkers, differential diagnosis, neuropathology and longitudinal progression to Alzheimer's dementia","volume":"26","author":"Janelidze","year":"2020","journal-title":"Nature Medicine"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib218","doi-asserted-by":"crossref","first-page":"387","DOI":"10.1038\/s41591-020-0762-2","article-title":"Diagnostic value of plasma phosphorylated tau181 in Alzheimer's disease and frontotemporal lobar degeneration","volume":"26","author":"Thijssen","year":"2020","journal-title":"Nature Medicine"},{"key":"10.1007\/s13311-021-01026-5_bib219","doi-asserted-by":"crossref","unstructured":"Moscoso, A., et al., Time course of phosphorylated-tau181 in blood across the Alzheimer's disease spectrum. Brain, 2020.","DOI":"10.1101\/2020.07.13.20152025"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib220","doi-asserted-by":"crossref","first-page":"1683","DOI":"10.1038\/s41467-020-15436-0","article-title":"Cerebrospinal fluid p-tau217 performs better than p-tau181 as a biomarker of Alzheimer's disease","volume":"11","author":"Janelidze","year":"2020","journal-title":"Nature Communications"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib221","doi-asserted-by":"crossref","first-page":"771","DOI":"10.1093\/brain\/awy347","article-title":"Plasma tau\/amyloid-\u03b21\u201342 ratio predicts brain tau deposition and neurodegeneration in Alzheimer's disease","volume":"142","author":"Park","year":"2019","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01026-5_bib222","doi-asserted-by":"crossref","unstructured":"Janelidze, S., et al., Associations of Plasma Phospho-Tau217 Levels With Tau Positron Emission Tomography in Early Alzheimer Disease. JAMA Neurology, 2020.","DOI":"10.1001\/jamaneurol.2020.4201"},{"issue":"11","key":"10.1007\/s13311-021-01026-5_bib223","doi-asserted-by":"crossref","first-page":"e1190","DOI":"10.1212\/WNL.0000000000008905","article-title":"Intermediate flortaucipir uptake is associated with A\u03b2-PET and CSF tau in asymptomatic adults","volume":"94","author":"McSweeney","year":"2020","journal-title":"Neurology"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib224","doi-asserted-by":"crossref","first-page":"e282","DOI":"10.1212\/WNL.0000000000004860","article-title":"Associations between 18F-AV1451 tau PET and CSF measures of tau pathology in a clinical sample","volume":"90","author":"La Joie","year":"2018","journal-title":"Neurology"},{"issue":"9","key":"10.1007\/s13311-021-01026-5_bib225","doi-asserted-by":"crossref","first-page":"1212","DOI":"10.15252\/emmm.201707809","article-title":"18F-AV-1451 and CSF T-tau and P-tau as biomarkers in Alzheimer's disease","volume":"9","author":"Mattsson","year":"2017","journal-title":"EMBO Molecular Medicine"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib226","doi-asserted-by":"crossref","first-page":"445","DOI":"10.1007\/s13760-019-01112-8","article-title":"CSF biomarkers and amyloid PET: concordance and diagnostic accuracy in a MCI cohort","volume":"119","author":"Spallazzi","year":"2019","journal-title":"Acta Neurologica Belgica"},{"issue":"5","key":"10.1007\/s13311-021-01026-5_bib227","doi-asserted-by":"crossref","first-page":"e388","DOI":"10.1212\/WNL.0000000000004887","article-title":"Comparing 18F-AV-1451 with CSF t-tau and p-tau for diagnosis of Alzheimer disease","volume":"90","author":"Mattsson","year":"2018","journal-title":"Neurology"},{"key":"10.1007\/s13311-021-01026-5_bib228","doi-asserted-by":"crossref","unstructured":"Wolters, E.E., et al., Regional [18 F] flortaucipir PET is more closely associated with disease severity than CSF p-tau in Alzheimer's disease. European journal of nuclear medicine and molecular imaging, 2020.","DOI":"10.1007\/s00259-020-04849-0"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib229","doi-asserted-by":"crossref","first-page":"508","DOI":"10.1001\/jamaneurol.2019.4749","article-title":"Characterization of Alzheimer Disease Biomarker Discrepancies Using Cerebrospinal Fluid Phosphorylated Tau and AV1451 Positron Emission Tomography","volume":"77","author":"Meyer","year":"2020","journal-title":"JAMA Neurology"},{"key":"10.1007\/s13311-021-01026-5_bib230","doi-asserted-by":"crossref","unstructured":"Reimand, J., et al., Association of amyloid-\u03b2 CSF\/PET discordance and tau load five years later. Neurology, 2020: p. https:\/\/doi.org\/10.1212\/WNL.0000000000010739.","DOI":"10.1101\/2020.01.29.20019539"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib231","doi-asserted-by":"crossref","first-page":"398","DOI":"10.1038\/s41591-020-0781-z","article-title":"A soluble phosphorylated tau signature links tau, amyloid and the evolution of stages of dominantly inherited Alzheimer's disease","volume":"26","author":"Barth\u00e9lemy","year":"2020","journal-title":"Nature Medicine"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib232","doi-asserted-by":"crossref","first-page":"130","DOI":"10.1186\/s40478-016-0399-z","article-title":"Post-mortem histopathology underlying \u03b2-amyloid PET imaging following flutemetamol F 18 injection","volume":"4","author":"Ikonomovic","year":"2016","journal-title":"Acta Neuropathologica Communications"},{"key":"10.1007\/s13311-021-01026-5_bib233","doi-asserted-by":"crossref","unstructured":"Seo, S.W., et al., Regional correlations between [11C]PIB PET and post-mortem burden of amyloid-beta pathology in a diverse neuropathological cohort. NeuroImage: Clinical, 2017. 13: p. 130\u2013137.","DOI":"10.1016\/j.nicl.2016.11.008"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib234","doi-asserted-by":"crossref","first-page":"310","DOI":"10.1001\/jamaneurol.2018.3692","article-title":"Correlation of In Vivo [18F]Flortaucipir With Postmortem Alzheimer Disease Tau Pathology","volume":"76","author":"Smith","year":"2019","journal-title":"JAMA Neurology"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib235","doi-asserted-by":"crossref","first-page":"65","DOI":"10.1186\/s13550-020-00653-x","article-title":"Comparison of regional flortaucipir PET with quantitative tau immunohistochemistry in three subjects with Alzheimer's disease pathology: a clinicopathological study","volume":"10","author":"Pontecorvo","year":"2020","journal-title":"EJNMMI Research"},{"issue":"7","key":"10.1007\/s13311-021-01026-5_bib236","doi-asserted-by":"crossref","first-page":"829","DOI":"10.1001\/jamaneurol.2020.0528","article-title":"Positron Emission Tomography Imaging With [18F]flortaucipir and Postmortem Assessment of Alzheimer Disease Neuropathologic Changes","volume":"77","author":"Fleisher","year":"2020","journal-title":"JAMA Neurology"},{"issue":"3\u20134","key":"10.1007\/s13311-021-01026-5_bib237","doi-asserted-by":"crossref","first-page":"131","DOI":"10.1159\/000504341","article-title":"Neurodegenerative Patterns of Cognitive Clusters of Early-Onset Alzheimer's Disease Subjects: Evidence for Disease Heterogeneity","volume":"48","author":"Phillips","year":"2019","journal-title":"Dementia and Geriatric Cognitive Disorders"},{"key":"10.1007\/s13311-021-01026-5_bib238","first-page":"122","article-title":"Alzheimer\u2019s disease: The influence of age on clinical heterogeneity through the human brain connectome","volume":"6","author":"Dickerson","year":"2017","journal-title":"Alzheimer\u2019s & Dementia: Diagnosis, Assessment & Disease Monitoring"},{"key":"10.1007\/s13311-021-01026-5_bib239","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1016\/j.neurobiolaging.2017.02.010","article-title":"Difference in imaging biomarkers of neurodegeneration between early and late-onset amnestic Alzheimer's disease","volume":"54","author":"Aziz","year":"2017","journal-title":"Neurobiology of Aging"},{"key":"10.1007\/s13311-021-01026-5_bib240","doi-asserted-by":"crossref","unstructured":"Parker, T.D., et al., Differences in hippocampal subfield volume are seen in phenotypic variants of early onset Alzheimer's disease. NeuroImage: Clinical, 2019. 21: p. 101632.","DOI":"10.1016\/j.nicl.2018.101632"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib241","doi-asserted-by":"crossref","first-page":"225","DOI":"10.1001\/jamaneurol.2019.3606","article-title":"Selective Vulnerability of the Nucleus Basalis of Meynert Among Neuropathologic Subtypes of Alzheimer Disease","volume":"77","author":"Hanna Al-Shaikh","year":"2020","journal-title":"JAMA Neurology"},{"issue":"21","key":"10.1007\/s13311-021-01026-5_bib242","doi-asserted-by":"crossref","first-page":"2176","DOI":"10.1212\/WNL.0000000000004670","article-title":"Alzheimer disease brain atrophy subtypes are associated with cognition and rate of decline","volume":"89","author":"Risacher","year":"2017","journal-title":"Neurology"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib243","doi-asserted-by":"crossref","first-page":"2594","DOI":"10.1007\/s11682-019-00212-6","article-title":"Age at onset reveals different functional connectivity abnormalities in prodromal Alzheimer's disease","volume":"14","author":"Pini","year":"2020","journal-title":"Brain Imaging and Behavior"},{"issue":"47","key":"10.1007\/s13311-021-01026-5_bib244","doi-asserted-by":"crossref","first-page":"E4502","DOI":"10.1073\/pnas.1317918110","article-title":"Regional variability of imaging biomarkers in autosomal dominant Alzheimer's disease","volume":"110","author":"Benzinger","year":"2013","journal-title":"Proceedings of the National Academy of Sciences"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib245","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1016\/S1474-4422(18)30028-0","article-title":"Spatial patterns of neuroimaging biomarker change in individuals from families with autosomal dominant Alzheimer's disease: a longitudinal study","volume":"17","author":"Gordon","year":"2018","journal-title":"The Lancet Neurology"},{"issue":"8","key":"10.1007\/s13311-021-01026-5_bib246","doi-asserted-by":"crossref","first-page":"804","DOI":"10.1016\/S1474-4422(15)00135-0","article-title":"Longitudinal assessment of neuroimaging and clinical markers in autosomal dominant Alzheimer's disease: a prospective cohort study","volume":"14","author":"Yau","year":"2015","journal-title":"The Lancet Neurology"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib247","doi-asserted-by":"crossref","first-page":"213","DOI":"10.1016\/S1474-4422(10)70323-9","article-title":"Pre-dementia clinical stages in presenilin 1 E280A familial early-onset Alzheimer's disease: a retrospective cohort study","volume":"10","author":"Acosta-Baena","year":"2011","journal-title":"The Lancet Neurology"},{"issue":"1","key":"10.1007\/s13311-021-01026-5_bib248","doi-asserted-by":"crossref","first-page":"17","DOI":"10.1186\/s13195-019-0468-1","article-title":"Striatal amyloid is associated with tauopathy and memory decline in familial Alzheimer's disease","volume":"11","author":"Hanseeuw","year":"2019","journal-title":"Alzheimer\u2019s Research & Therapy"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib249","doi-asserted-by":"crossref","first-page":"229","DOI":"10.1212\/WNL.0b013e31825fdf18","article-title":"Low PiB PET retention in presence of pathologic CSF biomarkers in Arctic <em>APP<\/em> mutation carriers","volume":"79","author":"Sch\u00f6ll","year":"2012","journal-title":"Neurology"},{"issue":"10","key":"10.1007\/s13311-021-01026-5_bib250","doi-asserted-by":"crossref","first-page":"1765","DOI":"10.1016\/j.neurobiolaging.2009.11.013","article-title":"Acceleration of cortical thinning in familial Alzheimer's disease","volume":"32","author":"Knight","year":"2011","journal-title":"Neurobiology of Aging"},{"issue":"4","key":"10.1007\/s13311-021-01026-5_bib251","doi-asserted-by":"crossref","first-page":"1063","DOI":"10.1093\/brain\/awz019","article-title":"Tau PET in autosomal dominant Alzheimer's disease: relationship with cognition, dementia and other biomarkers","volume":"142","author":"Gordon","year":"2019","journal-title":"Brain"},{"issue":"12","key":"10.1007\/s13311-021-01026-5_bib252","doi-asserted-by":"crossref","first-page":"1048","DOI":"10.1016\/S1474-4422(12)70228-4","article-title":"Brain imaging and fluid biomarker analysis in young adults at genetic risk for autosomal dominant Alzheimer's disease in the presenilin 1 E280A kindred: a case-control study","volume":"11","author":"Reiman","year":"2012","journal-title":"The Lancet Neurology"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib253","doi-asserted-by":"crossref","first-page":"865","DOI":"10.1002\/ana.22105","article-title":"Hippocampal hyperactivation in presymptomatic familial Alzheimer's disease","volume":"68","author":"Quiroz","year":"2010","journal-title":"Annals of Neurology"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib254","doi-asserted-by":"crossref","first-page":"1010","DOI":"10.1093\/brain\/awaa033","article-title":"Neuroinflammation and protein aggregation co-localize across the frontotemporal dementia spectrum","volume":"143","author":"Bevan-Jones","year":"2020","journal-title":"Brain"},{"key":"10.1007\/s13311-021-01026-5_bib255","doi-asserted-by":"crossref","unstructured":"Mecca, A.P., et al., In vivo measurement of widespread synaptic loss in Alzheimer\u2019s disease with SV2A PET. Alzheimer\u2019s & Dementia, 2020.","DOI":"10.1002\/alz.12097"},{"issue":"6","key":"10.1007\/s13311-021-01026-5_bib256","doi-asserted-by":"crossref","first-page":"929","DOI":"10.1002\/ana.24647","article-title":"White matter hyperintensities are a core feature of Alzheimer's disease: evidence from the dominantly inherited Alzheimer network","volume":"79","author":"Lee","year":"2016","journal-title":"Annals of neurology"},{"issue":"3","key":"10.1007\/s13311-021-01026-5_bib257","doi-asserted-by":"crossref","first-page":"272","DOI":"10.1016\/S1474-4422(11)70307-6","article-title":"Cerebral microinfarcts: the invisible lesions","volume":"11","author":"Smith","year":"2012","journal-title":"The Lancet Neurology"},{"issue":"11","key":"10.1007\/s13311-021-01026-5_bib258","doi-asserted-by":"crossref","first-page":"1523","DOI":"10.1038\/nn.4393","article-title":"Multimodal population brain imaging in the UK Biobank prospective epidemiological study","volume":"19","author":"Miller","year":"2016","journal-title":"Nature neuroscience"},{"issue":"12","key":"10.1007\/s13311-021-01026-5_bib259","doi-asserted-by":"crossref","first-page":"3379","DOI":"10.1002\/hbm.25023","article-title":"Grab-AD: Generalizability and reproducibility of altered brain activity and diagnostic classification in Alzheimer's Disease","volume":"41","author":"Jin","year":"2020","journal-title":"Human Brain Mapping"},{"key":"10.1007\/s13311-021-01026-5_bib260","doi-asserted-by":"crossref","unstructured":"Buciuc, M., et al., Utility of FDG-PET in diagnosis of Alzheimer-related TDP-43 proteinopathy. Neurology, 2020.","DOI":"10.1212\/WNL.0000000000009722"},{"issue":"18","key":"10.1007\/s13311-021-01026-5_bib261","doi-asserted-by":"crossref","first-page":"5424","DOI":"10.1002\/hbm.24782","article-title":"Applications of amyloid, tau, and neuroinflammation PET imaging to Alzheimer's disease and mild cognitive impairment","volume":"40","author":"Chandra","year":"2019","journal-title":"Human brain mapping"},{"issue":"2","key":"10.1007\/s13311-021-01026-5_bib262","doi-asserted-by":"crossref","first-page":"169","DOI":"10.2174\/1567205013666160620111408","article-title":"Non-Amyloid PET Imaging Biomarkers for Neurodegeneration: Focus on Tau Alpha-Synuclein and Neuroinflammation","volume":"14","author":"Catafau","year":"2017","journal-title":"Current Alzheimer research"},{"issue":"11","key":"10.1007\/s13311-021-01026-5_bib263","doi-asserted-by":"crossref","first-page":"1034","DOI":"10.1016\/S1474-4422(19)30283-2","article-title":"Biomarker-based prognosis for people with mild cognitive impairment (ABIDE): a modelling study","volume":"18","author":"van Maurik","year":"2019","journal-title":"The Lancet Neurology"}],"container-title":["Neurotherapeutics"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01026-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s13311-021-01026-5\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923011261?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S1878747923011261?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s13311-021-01026-5.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,10,30]],"date-time":"2025-10-30T07:02:34Z","timestamp":1761807754000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S1878747923011261"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2021,4]]},"references-count":263,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2021,4]]}},"alternative-id":["S1878747923011261"],"URL":"https:\/\/doi.org\/10.1007\/s13311-021-01026-5","relation":{},"ISSN":["1878-7479"],"issn-type":[{"value":"1878-7479","type":"print"}],"subject":[],"published":{"date-parts":[[2021,4]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Recent Advances in Imaging of Preclinical, Sporadic, and Autosomal Dominant Alzheimer's Disease","name":"articletitle","label":"Article Title"},{"value":"Neurotherapeutics","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1007\/s13311-021-01026-5","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2021 The American Society for Experimental NeuroTherapeutics, Inc. Published by Elsevier B.V. All rights reserved.","name":"copyright","label":"Copyright"}]}}